Description
3,4-Difluorobenzocurcumin is a derivative of curcumin that, like its parent compound, may display antioxidative, anti-inflammatory, chemopreventive, and antibacterial activities.
| Product Unit Size | Cost | Quantity | Stock |
|---|
3,4-Difluorobenzocurcumin is a derivative of curcumin that, like its parent compound, may display antioxidative, anti-inflammatory, chemopreventive, and antibacterial activities.
| Cas No. | 1170354-22-9 |
|---|---|
| Purity | ≥95% |
| Formula | C28H22F2O6 |
| Formula Wt. | 492.47 |
| Chemical Name | (1E,6E)-1,7-bis-(4-hydroxy-3-methosyphenyl) hepta-1,6-diene [4(3,4-difluorobenzaldehyde)]-3,5-dione |
| IUPAC Name | (1E,6E)-4-[(3,4-difluorophenyl)methylidene]-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione |
| Synonym | Difluorobenzocurcumin, 3,4-Difluorobenzocurcumin, CDF |
| Melting Point | 214-217°C |
| Solubility | DMSO, 110mg/mL |
| Appearance | Bright Yellow Powder |
| Store Temp | Ambient |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures | |
Okuda KS, Ng MF, Ruslan NF, et al. 3,4-Difluorobenzocurcumin inhibits Vegfc-Vegfr3-Erk signalling to block developmental lymphangiogenesis in zebrafish. Pharmaceuticals (Basel). 2021 Jun 26;14(7):614. PMID: 34206901.
NSAID; COX-2 inhibitor.
GHS-R1a agonist, γ-secretase inhibitor.
Fibrate; PPARα agonist.
Intermediate in the synthesis of purine analogs...
pan-RAF inhibitor
Endogenous peptide hormone fragment, involved i...
PKD inhibitor.
Cathepsin K inhibitor.
Endogenous neuropeptide hormone, lowers extrace...
Sesquiterpene lactone derived from Artemesia.
Peptide, confers resistance against macrolide a...
Allylamine; squalene oxidase and KSR1 inhibitor...
Mycotoxin produced by species of Aspergillus; D...
β-lactam cephalosporin; penicillin binding pro...
BRD2/3/4 inhibitor.
CDK9 inhibitor.
CRM1/XPO1 inhibitor.
Imaging agent; Maillard reaction inhibitor.
Calpain I/II inhibitor.
Phytoestrogen, flavonoid found in clover, soy, ...